Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease

Journal of Chinese Integrative Medicine

Volumn 10, Issue 9, 2012, Pages 1018-1024

  Wu, Na ^a   Song, Lu ^a   Yang, Xin Xin ^a   Wei, Jiang Lei ^b   Liu, Zhen Guo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese herbal; Drugs; Dyskinesia; G protein coupled receptor kinase 6; Levodopa; Parkinson's disease; Rats

Indexed keywords

ASCORBIC ACID; BENSERAZIDE; CHINESE DRUG; G PROTEIN COUPLED RECEPTOR KINASE 6; LEVODOPA; TIANQI PINGCHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DYSKINESIA; FOREBRAIN; IMMUNOHISTOCHEMISTRY; INVOLUNTARY MOVEMENT; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; DYSKINESIAS; G-PROTEIN-COUPLED RECEPTOR KINASES; LEVODOPA; MALE; PARKINSON DISEASE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867129717     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120911     Document Type: Article

References (16)

1. Liu ZG, Qi C. Motor complications of Parkinson's disease and its treatment strategies[J]. Zhonghua Yi Xue Za Zhi, 2009, 89(35): 2516-2519. Chinese.
2. Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodriguez-Diaz M. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits[J]. Neurology, 2004, 62(1 Suppl 1): S17-S30.
3. Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S, Axelrod JD, Cheyette BN, Simon MI, Lester HA, Schwarz J. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways[J]. J Neurosci, 2005, 25(8): 2157-2165.
4. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. β-arrestins and cell signaling[J]. Annu Rev Physiol, 2007, 69: 483-510.
5. Gurevich EV, Gurevich VV. Arrestins: ubiquitous regulators of cellular signaling pathways[J]. Genome Biol, 2006, 7(9): 236.
6. Wu N, Yang XX, Song L, Liu ZG. Relationship between G protein-coupled receptor kinase 6 and N-methyl-D-aspartate receptor in the mechanism study underlying motor complications in Parkinson's disease[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2011, 30(4): 327-331. Chinese with abstract in English.
7. Ba MW, Liu ZG, Kong M, Yang HQ, Chen SD, Lu GQ. The establishment and evaluation of a rat model of levodopa-induced dyskinesia[J]. Shanghai Jiao Tong Da Xue Xue Bao Yi Xue Ban, 2006, 26: 810-812. Chinese.
8. Bao XM. The rat brain in stereotaxic coordinates[M]. Beijing: People's Medical Publishing House, 2005. 16-35. Chinese.
9. Ba MW, Liu ZG, Kong M, Chen SD, Lu GQ. Relationship between motor complications of Parkinson's disease and phosphorylated GIuR1Ser845[J]. Zhonghua Shen Jing Ke Za Zhi, 2006, 39(12): 822-826. Chinese with abstract in English.
10. Kong M, Ba MW, Liu ZG. Research progress in motor complications of Parkinson's disease[J]. Zhonghua Yi Xue Za Zhi, 2009, 89(3): 210-212. Chinese.
11. Nanjing University of Chinese Medicine. Dictionary of traditional Chinese drugs. 2nd ed[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2006. 326-2086. Chinese.
12. Yuan CX, Ye Q, Wang J, Zhang Y, Yuan CG. Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias[J] J Chin Integr Med, 2008, 6(10): 1024-1028. Chinese with abstract in English.
13. Zhang QJ, Zhang YY, Huang WY. Traditional Chinese medicine in treatment of Parkinson's disease[J] J Chin Integr Med, 2004, 2(1): 75-77. Chinese with abstract in English.
14. Calabresi P, Giacomini P, Centonze D, Bernardi G. Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol. 2000; 47(4 Suppl 1): S60-S68.
15. Gurevich VV, Gurevich EV. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors[J]. Pharmacol Ther, 2006, 110(3): 465-502.
16. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking[J]. Proc Natl Acad Sci U S A, 2001, 98(4): 1601-1606